Lenalidomide mediated immune regulation in cancer immunotherapy
碩士 === 中華科技大學 === 健康科技研究所在職專班 === 99 === Recent preclinical and clinical findings suggest that the immunomodulatory drug (IMiDs) Lenalidomide has dual mechanism of action, involving both the direct tumoricidal activity and immunomodulation, which can result in rapid and sustained control of Multip...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/22555319154780341874 |